Clene Presents Preclinical Data Supporting CNM-Au8 for Parkinson's Disease

Clene Inc. announced positive preclinical data for CNM-Au8 in treating Parkinson's disease (PD). A novel neuronal model demonstrated CNM-Au8's abilit...
Home/KnloSights/Clinical Trial Updates/Clene Presents Preclinical Data Supporting CNM-Au8 for Parkinson's Disease